These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25575894)

  • 1. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
    Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
    Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
    Putti TC; Teh M; Lee YS
    Mod Pathol; 2004 Apr; 17(4):468-75. PubMed ID: 14976535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 6. Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
    Scola N; Segert HM; Stücker M; Altmeyer P; Gambichler T; Kreuter A
    Clin Exp Dermatol; 2014 Mar; 39(2):216-8. PubMed ID: 24524559
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiating keratoacanthoma from squamous cell carcinoma-In quest of the holy grail.
    Nagarajan P
    J Cutan Pathol; 2020 Apr; 47(4):418-420. PubMed ID: 31893469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
    Vasiljević N; Andersson K; Bjelkenkrantz K; Kjellström C; Månsson H; Nilsson E; Landberg G; Dillner J; Forslund O
    Int J Cancer; 2009 May; 124(10):2361-6. PubMed ID: 19165861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
    Lonsdorf AS
    Acta Derm Venereol; 2024 Sep; 104():. PubMed ID: 39233466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression of cyclooxygenase-2 in laryngeal squamous cell carcinoma and its relationship with MVD].
    Sun X; Ge R; Dong Q; Zheng C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Nov; 19(21):967-70. PubMed ID: 16494037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
    Ichikawa E; Ohnishi T; Watanabe S
    J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
    King DF; Barr RJ
    J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.
    Honma M; Kato N; Hashimoto M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Jan; 36(1):57-62. PubMed ID: 20456385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma.
    Ohashi A; Ishizaki M; Kawana S; Fukuda Y
    Pathol Int; 2004 Aug; 54(8):585-94. PubMed ID: 15260849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA; Ross JS; Sheehan CE; Carlson JA
    Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin.
    Vahlquist A; Andersson E; Coble BI; Rollman O; Törmä H
    J Invest Dermatol; 1996 May; 106(5):1070-4. PubMed ID: 8618041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Special nosological status of keratoacanthoma. Clinical, histological and comparative Feulgen-cytophotometric studies. 2. Clinical aspects of keratoacanthoma, discussion of Feulgen-cytophotometric findings].
    Ehlers G; Knoth W; Sandritter W
    Fortschr Med; 1976 Oct; 94(30):1732-5. PubMed ID: 992546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.